The role of Chemistry in drugs discovery

Authors

  • ASMAA Jawad Forensic DNA Center for Research and Training, Al-Nahrain University, Jadriya, Baghdad, Iraq.
  • Reem Husam Al-Tabra Forensic DNA Center for Research and Training, Al-Nahrain University, Jadriya, Baghdad, Iraq.
  • Baraa Watheq Forensic DNA Center for Research and Training, Al-Nahrain University, Jadriya, Baghdad, Iraq.

DOI:

https://doi.org/10.36320/ajb/v16.i1.15085

Keywords:

Organic compounds ,pharmaceutical,

Abstract

The function of the medicinal chemist in drug discovery has significantly evolved over the last 25 years, mostly due to the use of technologies like combinatorial chemistry and structure-based drug design. With a collective experience of over 50 years in medicinal chemistry, covering the last four decades, we will explore this evolving function by drawing on both our own experiences and those of others. Examining this historical viewpoint may provide valuable insights on enhancing the present drug discovery framework by enabling medicinal chemists to reclaim their creative involvement that played a significant part in previous achievements.

Downloads

Download data is not yet available.

References

D. C. Blakemore et al., "Organic synthesis provides opportunities to transform drug discovery," Nature chemistry, vol. 10, no. 4, pp. 383-394, 2018.

R. A. Khan, "Natural products chemistry: The emerging trends and prospective goals," Saudi pharmaceutical journal, vol. 26, no. 5, pp. 739-753, 2018.

H. A. Wittcoff, B. G. Reuben, and J. S. Plotkin, Industrial organic chemicals. John Wiley & Sons, 2012.

D. Taylor, "The pharmaceutical industry and the future of drug development," 2015.

S. M. Paul et al., "How to improve R&D productivity: the pharma

ceutical industry's grand challenge," Nature reviews Drug discovery, vol. 9, no. 3, pp. 203-214, 2010.

P. M. Danzon and M. A. Carrier, "The neglected concern of firm size in pharmaceutical mergers," 2021.

N. E. Thomford et al., "Natural products for drug discovery in the 21st century: innovations for novel drug discovery," International journal of molecular sciences, vol. 19, no. 6, p. 1578, 2018.

L. Kier, Molecular connectivity in chemistry and drug research. Elsevier, 2012.

C. Avendaño and J. C. Menendez, Medicinal chemistry of anticancer drugs. Elsevier, 2015.

H. Chopra et al., "An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management," Pharmaceuticals, vol. 16, no. 4, p. 581, 2023.

Y. Ogawa, E. Tokunaga, O. Kobayashi, K. Hirai, and N. Shibata, "Current contributions of organofluorine compounds to the agrochemical industry," Iscience, vol. 23, no. 9, 2020.

G. M. Cragg and D. J. Newman, "Biodiversity: A continuing source of novel drug leads," Pure and applied chemistry, vol. 77, no. 1, pp. 7-24, 2005.

S. Basavaraj and G. V. Betageri, "Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges," Acta Pharmaceutica Sinica B, vol. 4, no. 1, pp. 3-17, 2014.

R. Peraman et al., "Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance," Future Journal of Pharmaceutical Sciences, vol. 7, pp. 1-25, 2021.

D. T. Hoagland, J. Liu, R. B. Lee, and R. E. Lee, "New agents for the treatment of drug-resistant Mycobacterium tuberculosis," Advanced drug delivery reviews, vol. 102, pp. 55-72, 2016.

I. R. Baxendale, J. J. Hayward, S. V. Ley, and G. K. Tranmer, "Pharmaceutical strategy and innovation: An academics perspective," ChemMedChem: Chemistry Enabling Drug Discovery, vol. 2, no. 6, pp. 768-788, 2007.

A. Tkaczyk, K. Mitrowska, and A. Posyniak, "Synthetic organic dyes as contaminants of the aquatic environment and their implications for ecosystems: A review," Science of the total environment, vol. 717, p. 137222, 2020.

D. Banerjee, D. Rajput, S. Banerjee, and V. A. Saharan, "Artificial Intelligence and Its Applications in Drug Discovery, Formulation Development, and Healthcare," in Computer Aided Pharmaceutics and Drug Delivery: An Application Guide for Students and Researchers of Pharmaceutical Sciences: Springer, 2022, pp. 309-380.

. F. Massoud and S. S. Gambhir, "Molecular imaging in living subjects: seeing fundamental biological processes in a new light," Genes & development, vol. 17, no. 5, pp. 545-580, 2003.

B. David, J.-L. Wolfender, and D. A. Dias, "The pharmaceutical industry and natural products: historical status and new trends," Phytochemistry Reviews, vol. 14, pp. 299-315, 2015.

G. Walsh, Biopharmaceuticals: biochemistry and biotechnology. John Wiley & Sons, 2013.

B. S. Zolnik and N. Sadrieh, "Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs," Advanced drug delivery reviews, vol. 61, no. 6, pp. 422-427, 2009.

A. Abdolmaleki, A. Asadi, K. Gurushankar, T. K. Shayan, and F. A. Sarvestani, "Importance of nano medicine and new drug therapies for cancer," Advanced Pharmaceutical Bulletin, vol. 11, no. 3, p. 450, 2021.

R. Layard, "Mental health: the new frontier for labour economics," IZA Journal of Labor Policy, vol. 2, no. 1, pp. 1-16, 2013.

M. J. Armstrong and M. S. Okun, "Diagnosis and treatment of Parkinson disease: a review," Jama, vol. 323, no. 6, pp. 548-560, 2020.

R. Duncan and R. Gaspar, "Nanomedicine (s) under the microscope," Molecular pharmaceutics, vol. 8, no. 6, pp. 2101-2141, 2011.

R. C. Mohs and N. H. Greig, "Drug discovery and development: Role of basic biological research," Alzheimer's & Dementia: Translational Research & Clinical Interventions, vol. 3, no. 4, pp. 651-657, 2017.

R. B. Silverman and M. W. Holladay, The organic chemistry of drug design and drug action. Academic press, 2014.

B. E. Blass, Basic principles of drug discovery and development. Elsevier, 2015.

A. Sertkaya, H.-H. Wong, A. Jessup, and T. Beleche, "Key cost drivers of pharmaceutical clinical trials in the United States," Clinical Trials, vol. 13, no. 2, pp. 117-126, 2016.

J. A. DiMasi, R. W. Hansen, H. G. Grabowski, and L. Lasagna, "Cost of innovation in the pharmaceutical industry," Journal of health economics, vol. 10, no. 2, pp. 107-142, 1991.

R. Hirschmann, "Medicinal chemistry in the golden age of biology: lessons from steroid and peptide research," Angewandte Chemie International Edition in English, vol. 30, no. 10, pp. 1278-1301, 1991.

M. Attia, I. El-Gibaly, S. Shaltout, and G. Fetih, "Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels," International journal of pharmaceutics, vol. 276, no. 1-2, pp. 11-28, 2004.

P. A. Milligan, Pharmacokinetic Studies with Piroxicam. University of Glasgow (United Kingdom), 1991.

F. Darvas and L. Kovács, "CMT: A Solution Phase Combinatorial Chemistry Approach," High Throughput Screening: The Discovery of Bioactive Substances, p. 223, 1997.

K. BERTRAM G KATZUNG, "Basic & clinical pharmacology," 2021: EGC.

V. Sheehan, "Ziprasidone mesylate (Geodon for injection): the first injectable atypical antipsychotic medication," in Baylor University Medical Center Proceedings, 2003, vol. 16, no. 4: Taylor & Francis, pp. 497-501.

P. Bamfield, Research and development in the chemical and pharmaceutical industry. John Wiley & Sons, 2006.

I. Khanna, "Drug discovery in pharmaceutical industry: productivity challenges and trends," Drug discovery today, vol. 17, no. 19-20, pp. 1088-1102, 2012.

S. Ali, S. Sabir, N. Saif, N. Farooq, and H. A. Dad, "Fabrication and characterization of piroxicam loaded Nano emulsions for topical drug delivery to fight osteoarthritic pain," Drug Discovery, vol. 17, p. e8dd1009, 2023.

C. Yao, S. Zhang, L. Wang, and X. Tao, "Recent advances in polymorph discovery methods of organic crystals," Crystal Growth & Design, vol. 23, no. 1, pp. 637-654, 2022.

S. Ullah et al., "Synthesis and characterization of novel piroxicam derivatives and their antiglycation activity," Journal of Molecular Structure, vol. 1239, p. 130470, 2021.

A. Mittal, R. Ghai, A. Srivastava, D. P. Ghosh, and K. Nagarajan, "Pharmacokinetics and Pharmacodynamics: Fundamentals and Role (s) in Drug Discovery and Development," in Recent Advances in Pharmaceutical Innovation and Research: Springer, 2023, pp. 357-393.

C. J. Taylor et al., "A Brief Introduction to Chemical Reaction Optimization," Chemical Reviews, vol. 123, no. 6, pp. 3089-3126, 2023.

C. Song, D. Li, J. Zhang, and X. Zhao, "Role of ferroptosis in promoting cardiotoxicity induced by Imatinib Mesylate via down-regulating Nrf2 pathways in vitro and in vivo," Toxicology and Applied Pharmacology, vol. 435, p. 115852, 2022.

A. Dasgupta, S. Ghosh, K. Kalidass, and S. Farisha, "Drug discovery and repositioning for glioblastoma multiforme and low-grade astrocytic tumors," in Computational Methods in Drug Discovery and Repurposing for Cancer Therapy: Elsevier, 2023, pp. 147-200.

T. P. Braun, C. A. Eide, and B. J. Druker, "Response and resistance to BCR-ABL1-targeted therapies," Cancer Cell, vol. 37, no. 4, pp. 530-542, 2020.

Downloads

Published

2024-04-30

How to Cite

Jawad, A., Husam Al-Tabra, R., & Watheq, B. (2024). The role of Chemistry in drugs discovery. Al-Kufa University Journal for Biology, 16(1), 110-119. https://doi.org/10.36320/ajb/v16.i1.15085

Share